Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

• Main Authors: Sruamsiri Rosarin (Author), Chaiyakunapruk Nathorn (Author), Pakakasama Samart (Author), Sirireung Somtawin (Author), Sripaiboonkij Nintita (Author), Bunworasate Udomsak (Author), Hongeng Suradej (Author)
• Format: Book
• Published: BMC, 2013-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Hematopoieticic stem cell transplantation is the only therapeutic option that can cure thalassemia disease. Reduced intensity hematopoietic stem cell transplantation (RI-HSCT) has demonstrated a high cure rate with minimal complicati...